| Charles B Stevenson, MD | |
|
3333 Burnet Ave., Ml 2016, Cincinnati Children's Hospital, Cincinnati, OH 45229-3039 | |
| (513) 636-4726 | |
| (513) 636-2808 |
| Full Name | Charles B Stevenson |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 23 Years |
| Location | 3333 Burnet Ave., Ml 2016, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457408338 | NPI | - | NPPES |
| 3730541000 | Other | KY | PASSPORT ADVANTAGE - NNIKY |
| 106186 | Other | KY | SIHO - NNIKY |
| 200963990 | Medicaid | IN | |
| 9877110 | Other | KY | CIGNA - NNIKY |
| 000026447V | Other | KY | HUMANA - NNIKY |
| 000000642009 | Other | KY | ANTHEM - NNIKY |
| 7100077020 | Medicaid | KY | |
| 50025169 | Other | KY | PASSPORT - NNIKY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 35.091452 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Children's Hospital Medical Center | 8426955733 | 473 |
News Archive
A new AP poll finds that Americans who think the law should have done more outnumber those who think the government should stay out of health care by 2-to-1. The poll found that about four in 10 adults think the new law did not go far enough to change the health care system, regardless of whether they support the law, oppose it or remain neutral.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).
Inflammatory bowel disease (IBD), of which Crohn's disease and ulcerative colitis are the main types, is on the increase in the United States, affecting more than 1.6 million people and explaining perhaps the increase in advertisements offering treatments and cures.
Bio-Tissue, the industry leader in Ophthalmic tissue products, announced today that it has shipped over 7,500 ProKera units since the product's inception. ProKera is the only medical device that can provide wound healing to over 350,000 annual cases of patients afflicted with damaged ocular surfaces.
› Verified 8 days ago
| Entity Name | Children's Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609915784 PECOS PAC ID: 8426955733 Enrollment ID: O20031216000035 |
News Archive
A new AP poll finds that Americans who think the law should have done more outnumber those who think the government should stay out of health care by 2-to-1. The poll found that about four in 10 adults think the new law did not go far enough to change the health care system, regardless of whether they support the law, oppose it or remain neutral.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).
Inflammatory bowel disease (IBD), of which Crohn's disease and ulcerative colitis are the main types, is on the increase in the United States, affecting more than 1.6 million people and explaining perhaps the increase in advertisements offering treatments and cures.
Bio-Tissue, the industry leader in Ophthalmic tissue products, announced today that it has shipped over 7,500 ProKera units since the product's inception. ProKera is the only medical device that can provide wound healing to over 350,000 annual cases of patients afflicted with damaged ocular surfaces.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles B Stevenson, MD 3333 Burnet Ave., Ml 2016, Cincinnati Children's Hospital, Cincinnati, OH 45229-3039 Ph: (513) 636-4726 | Charles B Stevenson, MD 3333 Burnet Ave., Ml 2016, Cincinnati Children's Hospital, Cincinnati, OH 45229-3039 Ph: (513) 636-4726 |
News Archive
A new AP poll finds that Americans who think the law should have done more outnumber those who think the government should stay out of health care by 2-to-1. The poll found that about four in 10 adults think the new law did not go far enough to change the health care system, regardless of whether they support the law, oppose it or remain neutral.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).
Inflammatory bowel disease (IBD), of which Crohn's disease and ulcerative colitis are the main types, is on the increase in the United States, affecting more than 1.6 million people and explaining perhaps the increase in advertisements offering treatments and cures.
Bio-Tissue, the industry leader in Ophthalmic tissue products, announced today that it has shipped over 7,500 ProKera units since the product's inception. ProKera is the only medical device that can provide wound healing to over 350,000 annual cases of patients afflicted with damaged ocular surfaces.
› Verified 8 days ago
Dr. Dale S Horne, MD, PHD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3113 Bellevue Ave Ste 4100, Cincinnati, OH 45219 Phone: 513-475-8990 Fax: 513-475-8577 | |
Daniel Barnes Webb, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3113 Bellevue Ave, Cincinnati, OH 45219 Phone: 513-475-8990 Fax: 513-475-8577 | |
Dr. Michael J Kramer, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 9250 Blue Ash Rd, Cincinnati, OH 45242 Phone: 513-792-7445 Fax: 513-792-7451 | |
Dr. Thomas S Berger, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3825 Edwards Rd, Suite 300, Cincinnati, OH 45209 Phone: 513-221-1100 Fax: 513-569-5297 | |
Joseph Cheng, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 Piedmont Ave, Cincinnati, OH 45219 Phone: 513-558-1177 Fax: 513-475-7243 | |
Dr. Yannick Grenier, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4805 Montgomery Rd Ste 210, Cincinnati, OH 45212 Phone: 513-791-8080 Fax: 513-791-8085 | |
Dr. Michael C Kachmann, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3825 Edwards Rd, Suite 300, Cincinnati, OH 45209 Phone: 513-221-1100 Fax: 513-569-5297 |